User profiles for M. Ghert

Michelle Ghert

University of Maryland
Verified email at mcmaster.ca
Cited by 8489

A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma

…, R Tozer, A Figueredo, M Ghert - … Journal of the …, 2008 - Wiley Online Library
… In these trials the doxorubicin dosage ranged from 50 to 90 mg/m 2 per cycle and ifosfamide
… chemotherapy LT alone 70mg/m 2 per cycle, 490mg/m 2 total Overall recurrence, survival …

[HTML][HTML] Lost in translation: animal models and clinical trials in cancer treatment

IWY Mak, N Evaniew, M Ghert - American journal of translational …, 2014 - ncbi.nlm.nih.gov
Due to practical and ethical concerns associated with human experimentation, animal
models have been essential in cancer research. However, the average rate of successful …

2018 International consensus meeting on musculoskeletal infection: research priorities from the general assembly questions

…, M Citak, K Egol, GE Garrigues, M Ghert… - Journal of …, 2019 - Wiley Online Library
Musculoskeletal infections (MSKI) remain the bane of orthopedic surgery, and result in grievous
illness and inordinate costs that threaten healthcare systems. As prevention, diagnosis, …

Pathologic fracture in osteosarcoma: prognostic importance and treatment implications

SP Scully, MA Ghert, D Zurakowski, RC Thompson… - JBJS, 2002 - journals.lww.com
Background: The presence of a pathologic fracture in an osteosarcoma has been considered
a poor prognostic factor and an indication for immediate amputation. The purpose of the …

[HTML][HTML] Synovial sarcoma: a clinical review

…, S Popovic, S Munir, N Parasu, D Wilson, M Ghert - Current …, 2021 - mdpi.com
Synovial sarcomas (SS) represent a unique subset of soft tissue sarcomas (STS) and account
for 5–10% of all STS. Synovial sarcoma differs from other STS by the relatively young age …

The fragility of statistically significant findings from randomized trials in spine surgery: a systematic survey

…, C Files, C Smith, M Bhandari, M Ghert, M Walsh… - The Spine Journal, 2015 - Elsevier
Background context Randomized controlled trials (RCTs) are the most trustworthy source
for evaluating treatment effects, but RCTs of spine surgery interventions often produce …

Treatment of osseous metastases in patients with renal cell carcinoma.

ST Jung, MA Ghert, JM Harrelson… - … and Related Research …, 2003 - journals.lww.com
The records of 99 patients treated at one institution for osseous metastases secondary to
renal cell carcinoma were reviewed. Patients were followed up for at least 24 months or until …

Myxoid\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases

…, B Masri, M Isler, N Dion, J Werier, M Ghert… - Annals of Surgical …, 2012 - Springer
Background Objectives of this study were to evaluate oncologic outcomes and to provide
guidelines for the management of primary myxoid (MLS) and round cell liposarcoma (RCLS). …

[HTML][HTML] Interpreting regression models in clinical outcome studies

DF Hamilton, M Ghert, A Simpson - Bone & Joint Research, 2015 - boneandjoint.org.uk
Measuring the outcome of an intervention is central to the practice of evidence based medicine,
and most research papers evaluating patient outcomes now incorporate some form of …

[HTML][HTML] High-speed burring with and without the use of surgical adjuvants in the intralesional management of giant cell tumor of bone: a systematic review and meta …

H Algawahmed, R Turcotte, F Farrokhyar, M Ghert - Sarcoma, 2010 - hindawi.com
Local control rates for Giant Cell Tumor of Bone (GCT) have been reported in a large number
of retrospective series. However, there remains a lack of consensus with respect to the …